← back to search

Musa Mayer

UPMC Hillman Cancer Center · US
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Medicine, Breast cancer, Internal medicine, Oncology, Metastatic breast cancer, and Hazard ratio.
h-index
citations
5,080
works
13
NIH funding
primary concept
email

Recent publications

Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011
Cancer 2019cited by 35position: middledoi
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
Annals of Oncology 2018cited by 1,185position: middledoi
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
Annals of Oncology 2016cited by 2,062position: middledoi
3rd ESO–ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3)
The Breast 2016cited by 232position: middledoi
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
Annals of Oncology 2014cited by 539position: middledoi
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
The Breast 2014cited by 332position: middledoi
Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer
Breast Cancer Research and Treatment 2014cited by 86position: middledoi
Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2‐negative breast cancer
Cancer 2014cited by 67position: middledoi
Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER
British Journal of Cancer 2014cited by 61position: middledoi
First-Line Treatment Patterns and Clinical Outcomes in Patients With HER2-Positive and Hormone Receptor-Positive Metastatic Breast Cancer From registHER
The Oncologist 2013cited by 74position: middledoi
Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer
Breast Cancer Research and Treatment 2013cited by 54position: middledoi
1st International consensus guidelines for advanced breast cancer (ABC 1)
The Breast 2012cited by 298position: middledoi
Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study
Breast Cancer Research and Treatment 2012cited by 55position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Peter A. Kaufman · University of Vermont6 papers (2012–2014)Denise A. Yardley · Lublin Oncology Center6 papers (2012–2014)Hope S. Rugo · UCSF Helen Diller Family Comprehensive Cancer Center6 papers (2012–2014)Debu Tripathy · The University of Texas MD Anderson Cancer Center5 papers (2012–2014)Adam Brufsky · UPMC Hillman Cancer Center5 papers (2012–2014)Marianne Ulcickas Yood · Nutrasource5 papers (2012–2014) · 4 papers (2013–2014)Cheng S. Quah · Principia Biopharma (United States)4 papers (2012–2014) · 1 papers (2014–2014)B. Yoo · UPMC Hillman Cancer Center1 papers (2014–2014)Charles L. Vogel · Kaiser Permanente San Francisco Medical Center1 papers (2014–2014)Gregory S. Calip · University of Southern California1 papers (2019–2019)Shibao Feng · Fitbit (United States)1 papers (2012–2012)Henry G. Kaplan · University of California System1 papers (2019–2019) · 1 papers (2014–2014)Judith A. Malmgren · Seattle University1 papers (2019–2019) · 1 papers (2012–2012)Julie R. Gralow · University of Washington1 papers (2014–2014)Mark D. Pegram · Stanford University1 papers (2014–2014)Melissa Brammer · Amgen (United States)1 papers (2014–2014)